Amdocs Limited (NASDAQ:DOX) Shares Acquired by Northern Trust Corp

Northern Trust Corp lifted its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 25.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 880,808 shares of the technology company's stock after purchasing an additional 177,061 shares during the quarter. Northern Trust Corp owned approximately 0.78% of Amdocs worth $74,992,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp acquired a new stake in shares of Amdocs during the fourth quarter worth about $36,000. SBI Securities Co. Ltd. acquired a new stake in Amdocs during the 4th quarter worth approximately $41,000. Global Retirement Partners LLC grew its stake in shares of Amdocs by 45.6% in the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock valued at $48,000 after purchasing an additional 175 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after purchasing an additional 208 shares during the period. Finally, Private Trust Co. NA raised its stake in shares of Amdocs by 121.5% during the fourth quarter. Private Trust Co. NA now owns 671 shares of the technology company's stock worth $57,000 after purchasing an additional 368 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.

Amdocs Stock Up 0.3 %

Amdocs stock opened at $89.67 on Tuesday. The stock's 50 day moving average price is $87.05 and its 200 day moving average price is $86.96. The company has a market cap of $10.12 billion, a PE ratio of 20.81, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $93.34.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, sell-side analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, Amdocs has a consensus rating of "Moderate Buy" and an average target price of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.